Skip to main content
SpringerLink
Log in

Probiotics as Anti-Inflammatory Agents in Inflammatory Bowel Disease and Irritable Bowel Syndrome

  • Chapter
  • First Online:
Probiotic Research in Therapeutics

Abstract

Studies involving manipulation of intestinal microflora with probiotic species have suggested potential effectiveness in multiple gastrointestinal diseases including inflammatory bowel diseases. Resulting benefits of probiotics include competitively excluding pathogens, improvement of mucosal barrier function, and hence maintaining the gut homeostasis and modulating the immune system by inducing the release of cytokines. Few lactobacillus strains are also known to modulate the perception of pain by inducing effects similar to that of morphine in the intestinal epithelial cells. Probiotic products like VSL#3 (Bifidobacterium longum, B. breve, B. infantis, Lactobacillus plantarum, L. acidophilus, L. paracasei, L. bulgaricus, Streptococcus thermophilus), Culturelle (L. rhamnosus GG), Florastor (S. boulardii), Align (B. infantis), DanActive (L. casei), Mutaflor (E. coli Nissle 1917) are current examples of treatments. Probiotics are also increasingly being added in dairy as well as non-dairy products like drinks, yoghurts, etc. Most studies regarding the anti-inflammatory effects of probiotics are preliminary and seem promising but require further clinical trials. There is also scope for studies on the dosage, duration of therapies, ways of administration, and strain combinations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Andresen V, Baumgart DC (2006) Role of probiotics in the treatment of irritable bowel syndrome: potential mechanisms and current clinical evidence. Int J Probiotics Prebiotics 1(1):11

    Google Scholar 

  • Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174–180

    Article  CAS  Google Scholar 

  • Basso PJ, Câmara NOS, Sales-Campos H (2018) Microbial-based therapies in the treatment of inflammatory bowel disease–an overview of human studies. Front Pharmacol 9:1571

    Article  CAS  Google Scholar 

  • Bennet SM, Öhman L, Simrén M (2015) Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver 9(3):318

    Article  Google Scholar 

  • Canavan C, West J, Card T (2014) The epidemiology of irritable bowel syndrome. Clin Epidemiol 6:71

    PubMed  PubMed Central  Google Scholar 

  • Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Huntley J, Fierer N, Owens SM, Betley J, Fraser L, Bauer M, Gormley N (2012) Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms. ISME J 6(8):1621–1624

    Article  CAS  Google Scholar 

  • Celiberto LS, Bedani R, Rossi EA, Cavallini DCU (2017) Probiotics: the scientific evidence in the context of inflammatory bowel disease. Crit Rev Food Sci Nutr 57(9):1759–1768

    CAS  PubMed  Google Scholar 

  • Chermesh I, Eliakim R (2006) Probiotics and the gastrointestinal tract: where are we in 2005? World J Gastroenterol: WJG 12(6):853

    Article  CAS  Google Scholar 

  • Day RL, Harper AJ, Woods RM, Davies OG, Heaney LM (2019) Probiotics: current landscape and future horizons. Fut Sci OA 5(4):FSO391

    Article  CAS  Google Scholar 

  • Dignass A, Lindsay JO, Sturm A, Windsor A, Colombel JF, Allez M, D'Haens G, D'Hoore A, Mantzaris G, Novacek G, Öresland T (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohn’s Colitis 6(10):991–1030

    Article  Google Scholar 

  • Enck P, Zimmermann K, Menke G, Klosterhalfen S (2009) Randomized controlled treatment trial of irritable bowel syndrome with a probiotic E.-coli preparation (DSM17252) compared to placebo. Zeitschriftfür Gastroenterologie 47(02):209–214

    Article  CAS  Google Scholar 

  • Guarner F, Khan AG, Garisch J, Eliakim R, Gangl A, Thomson A, Krabshuis J, Lemair T, Kaufmann P, De Paula JA, Fedorak R (2012) World gastroenterology organisation global guidelines: probiotics and prebiotics October (2011). J Clin Gastroenterol 46(6):468–481

    Article  Google Scholar 

  • Guslandi M, Mezzi G, Sorghi M, Testoni PA (2000) Saccharomyces boulardii in maintenance treatment of Crohn’s disease. Dig Dis Sci 45(7):1462–1464

    Article  CAS  Google Scholar 

  • Kajander K, Myllyluoma E, Rajilić-Stojanović M, Kyrönpalo S, Rasmussen M, Järvenpää S, Korpela R (2008) Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota. Aliment Pharmacol Ther 27(1):48–57

    Article  CAS  Google Scholar 

  • Kruis W, Frič P, Pokrotnieks J, Lukáš M, Fixa B, Kaščák M, Wolff C (2004) Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 53(11):1617–1623

    Article  CAS  Google Scholar 

  • Li F, Duan K, Wang C, McClain C, Feng W (2016) Probiotics and alcoholic liver disease: treatment and potential mechanisms. Gastroenterol Res Pract 2016:5491465. https://doi.org/10.1155/2016/5491465. Epub 2015 Dec 29

    Article  PubMed  Google Scholar 

  • Mack DR (2011) Probiotics in inflammatory bowel diseases and associated conditions. Nutrients 3(2):245–264

    Article  Google Scholar 

  • Mahdi BM (2018) Introductory Chapter: inflammatory bowel disease. In: New concepts in inflammatory bowel disease. IntechOpen

    Google Scholar 

  • Marteau P, Seksik P, Jian R (2002) Probiotics and intestinal health effects: a clinical perspective. Br J Nutr 88(S1):s51–s57

    Article  CAS  Google Scholar 

  • Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC (2008) Mechanisms of action of probiotics: recent advances. Inflamm Bowel Dis 15(2):300–310

    Article  Google Scholar 

  • Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B (2000) Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 95(5):1231–1238

    Article  CAS  Google Scholar 

  • Oelschlaeger TA (2010) Mechanisms of probiotic actions–a review. Int J Med Microbiol 300(1):57–62

    Article  CAS  Google Scholar 

  • Pagnini C, Delle Fave G, Bamias G (2013) Probiotics in inflammatory bowel disease: pathophysiological background and clinical applications. World J Immunol 3(3):31–43

    Article  Google Scholar 

  • Panghal A, Janghu S, Virkar K, Gat Y, Kumar V, Chhikara N (2018) Potential non-dairy probiotic products–a healthy approach. Food Biosci 21:80–89

    Article  CAS  Google Scholar 

  • Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon ATR (1999) Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354(9179):635–639

    Article  CAS  Google Scholar 

  • Spiller R, Major G (2016) IBS and IBD—separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol 13(10):613–621

    Article  CAS  Google Scholar 

  • Vasudha S, Mishra HN (2013) Non dairy probiotic beverages. Int Food Res J 20(1)

    Google Scholar 

  • Veerappan GR, Betteridge J, Young PE (2012) Probiotics for the treatment of inflammatory bowel disease. Curr Gastroenterol Rep 14(4):324–333

    Article  Google Scholar 

  • Whelan K, Quigley EM (2013) Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol 29(2):184–189

    Article  Google Scholar 

  • Zhu B, Wang X, Li L (2010) Human gut microbiome: the second genome of human body. Protein Cell 1(8):718–725

    Article  Google Scholar 

  • Zigra PI, Maipa VE, Alamanos YP (2007) Probiotics and remission of ulcerative colitis: a systematic review. Neth J Med 65(11):411–418

    CAS  PubMed  Google Scholar 

  • Zocco MA, Dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M, Armuzzi A (2006) Efficacy of lactobacillus GG in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther 23(11):1567–1574

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Food Technology, Jamia Hamdard (Deemed to be University), New Delhi, India

    Vasudha Sharma & Pritika Sharma

Authors
  1. Vasudha Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pritika Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vasudha Sharma .

Editor information

Editors and Affiliations

  1. University Institute of Pharmaceutical Sciences, Chandigarh, Punjab, India

    Sandip V. Pawar

  2. Department of Microbiology, Panjab University, Chandigarh, Punjab, India

    Praveen Rishi

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive licence to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sharma, V., Sharma, P. (2021). Probiotics as Anti-Inflammatory Agents in Inflammatory Bowel Disease and Irritable Bowel Syndrome. In: Pawar, S.V., Rishi, P. (eds) Probiotic Research in Therapeutics. Springer, Singapore. https://doi.org/10.1007/978-981-33-6236-9_5

Download citation

Publish with us

Policies and ethics

Search

Navigation